Jaguar Market Capitalization from 2010 to 2024
| JAGX Stock | USD 1.00 0.03 2.91% |
Check Jaguar Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jaguar Animal's main balance sheet or income statement drivers, such as Interest Expense of 4.4 M, Selling General Administrative of 12.5 M or Total Revenue of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.0 or PTB Ratio of 0.67. Jaguar financial statements analysis is a perfect complement when working with Jaguar Animal Valuation or Volatility modules.
Jaguar | Market Capitalization |
Latest Jaguar Animal's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Jaguar Animal Health over the last few years. It is Jaguar Animal's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jaguar Animal's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 11.8 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Jaguar Market Capitalization Regression Statistics
| Arithmetic Mean | 1,000,579,267 | |
| Geometric Mean | 453,559,123 | |
| Coefficient Of Variation | 67.75 | |
| Mean Deviation | 636,224,613 | |
| Median | 1,597,039,842 | |
| Standard Deviation | 677,915,313 | |
| Sample Variance | 459569.2T | |
| Range | 1.6B | |
| R-Value | (0.89) | |
| Mean Square Error | 106673.8T | |
| R-Squared | 0.78 | |
| Significance | 0.000011 | |
| Slope | (134,259,990) | |
| Total Sum of Squares | 6433968.4T |
Jaguar Market Capitalization History
About Jaguar Animal Financial Statements
Jaguar Animal investors use historical fundamental indicators, such as Jaguar Animal's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jaguar Animal. Please read more on our technical analysis and fundamental analysis pages.
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California. Jaguar Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jaguar Stock Analysis
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.